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Abstract: OBJECTIVE To test whether or not topically administered recombinant human epidermal
growth factor (rhEGF) accelerates the early healing phase of oral soft tissue wounds. METHODS One
day following the creation of palatal defects (n = 6/animal), 14 dogs were allocated to one of the following
five groups: spontaneous healing (SH), vehicle ointment (V), vehicle ointment + rhEGF at concentra-
tions of 1 ฀g/g (EGF1), 10 ฀g/g (EGF10) or 50 ฀g/g (EGF50). Topical administration of ointments was
repeated twice per day until sacrifice at days 8 and 16. Wound area was clinically monitored. Ker-
atinocytes proliferation (Ki67-immunolabelling), inflammatory response (IR) and areas of collagen (C)
and granulation tissue (GT) were histologically measured. Kruskal-Wallis test with Dunnett correction
was used for multiple group statistical comparisons. RESULTS Clinically, in comparison with SH, a
significantly smaller wound area was observed in groups EGF1 and EGF10 at day 8 (p < 0.05). At day
16, wound closure reached 97.8% in group EGF1 compared to 83.2% in group SH, albeit no statistically
different. Histologically, at day 8, significantly more GT was observed in group EGF10 compared to all
other groups (p < 0.05). At day 16, in addition to a higher Ki67-immunolabelling, groups EGF1 and
EGF10 demonstrated a significant decrease in GT and IR with more deposition of C compared to the
other groups (p < 0.05). CONCLUSION Application of rhEGF enhanced the early healing of acute oral
soft tissue wounds compared to SH, predominantly at concentrations of 1 and 10 ฀g/g.
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Objective: To test whether or not topically administered recombinant human epidermal 
growth factor (rhEGF) accelerates the early healing phase of oral soft tissue wounds.   
Methods: One day following the creation of palatal defects (n=6/animal), 14 dogs were 
allocated to one of the following five groups: spontaneous healing (SH), vehicle ointment (V), 
vehicle ointment + rhEGF at concentrations of 1µg/g (EGF1), 10µg/g (EGF10) or 50µg/g 
(EGF50). Topical administration of ointments was repeated twice per day until sacrifice at days 
8 and 16. Wound area was clinically monitored. Keratinocytes proliferation (Ki67-
immunolabelling), inflammatory response (IR) and areas of collagen (C) and granulation tissue 
(GT) were histologically measured. Kruskal-Wallis test with Dunnett correction was used for 
multiple group statistical comparisons. 
Results: Clinically, in comparison with SH, a significantly smaller wound area was observed in 
groups EGF1 and EGF10 at day 8 (p<0.05). At day 16, wound closure reached 97.8% in group 













This article is protected by copyright. All rights reserved. 
significantly more GT was observed in group EGF10 compared to all other groups (p<0.05). At 
day 16, in addition to a higher Ki67-immunolabelling, groups EGF1 and EGF10 demonstrated a 
significant decrease in GT and IR with more deposition of C compared to the other groups 
(p<0.05). 
Conclusion: Application of rhEGF enhanced the early healing of acute oral soft tissue wounds 
compared to SH, predominantly at concentrations of 1µg/g and 10µg/g. 
 
CLINICAL RELEVANCE 
Scientific rationale for study: Epidermal growth factor demonstrated to facilitate primary and 
secondary wound healing of the skin. This study aimed to clinically and histologically verify the 
effect of topical administration of recombinant human epidermal growth factor (rhEGF) on the 
early healing of open oral soft tissue wounds. 
Principal findings: In comparison to spontaneously healing wounds, rhEGF not only increased 
the wound closure rate during the first week, but also significantly improved the quality of the 
wound healing at 16 days.  
Practical implications: RhEGF accelerated the healing of oral soft tissue wounds. 
 
1- INTRODUCTION 
Oral soft tissue repair is characterized by either a primary or a secondary intention healing. 
Primary intention healing results when the edges of the wound are closely approximated while 
in secondary intention healing, the wound edges remain distant(Polimeni et al.,2006). 
Oftentimes, excising diseased gingival tissue, curetting root surfaces, avulsing hopeless teeth, or 
apically positioning the flapped tissues are prevalent clinical scenarios where wound repair 
exclusively rely upon secondary intention healing(Harrison et al.,1991). Open wounds heal de 
facto with the same basic process of inflammation, proliferation and remodelling as do closed 
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completed. A factor of healing delay is the considerable amount of granulation tissue necessary 
to bridge the distant wound edges in the setting of open injuries(Clark et al.,1996). 
 To accelerate the repair of soft tissue wounds, regenerative medicine approaches have 
been applied including growth factors used alone or in combination(Kaigler et al.,2006). 
Preclinical and clinical studies resonate that growth factor-driven treatments are helpful 
boosting the innate healing potential(Schliephake et al.,2002). Prominent among these is the 
strategy whereby epidermal growth factor(EGF) is engaged in productive skin repair(Brown et 
al.,1989; Bodnar et al.,2013). As the first growth factor to be isolated, and one of the first to be 
synthesised using recombinant DNA technology, EGF has been extensively investigated in 
dermal wound healing(Brake et al.,1984;Hong et al.,2006;Tanaka et al.,2005). According to 
recent systematic reviews, topical interventions using recombinant human EGF (rhEGF) in 
clinical settings are robust protocols to promote healing of cutaneous aberrations such as 
diabetic ulcers or burn injuries(Martí-Carvajal et al.,2010;Zhang et al.,2014).  
In a similar fashion, this potential of EGF has also captured scientific interest with the 
endeavour to achieve periodontal regeneration. The available data suggest the promise of EGF 
purposed at improving oral wound healing. To recapitulate, stimulation of proliferation and 
migration of oral keratinocytes, stimulation of gingival fibroblasts mitogenesis and increase of 
collagen synthesis(Kim et al.,2011;Pansani et al.,2017;Ramineni et al.,2015) are among the 
cellular events through which exogenous EGF is harnessed to facilitate the wound repair in 
vitro.  Nevertheless, whether EGF-based treatment is able to facilitate the repair of acute 
injuries healing by secondary intention remains unknown. In vivo data are missing in terms of 
(i) the early phases of open oral soft tissue wounds treated with rhEGF and, (ii) possible effects 
of dosage differential on wound repair. 
The aim of this study was to test, in an animal model of acute open oral mucosa wound, whether 
or not topical application of rhEGF can improve early wound healing compared to spontaneous 
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2- MATERIALS AND METHODS 
2.1- Animals 
Fourteen 1-year old, 10kg-weighing beagle dogs were used for the purpose of this experimental 
study, conducted following approval by the Institutional Animal Care and Use Committee, 
Cronex, Hwasung, Korea(CRONEX-IACUC 201701001).  
All surgical and follow-up interventions were performed under general anaesthesia in an 
operating room and under sterile conditions. General anaesthesia was induced by the injection 
of tiletamine/zolazepam(0.1mg/kg)(Zoletil, France), xylazine(2.3mg/kg)(Rompun, Korea), and 
atropine sulfate(0.05mg/kg)(Jeil, Korea). Further analgesia was given for 3 days following 
surgical procedures(Zipan, Korea). Throughout the experiment period, all animals were housed 
individually and had ad libitum access to water and laboratory soft dog-food.  
 
2.3- Experimental procedures 
2.3.1- Agents 
Semi-solid preparations were used for the application on the oral mucosa of rhEGF(Daewoong, 
Korea) adjusted to concentrations of 1µg/g, 10µg/g and 50µg/g. Gelatin, pectin and sodium 
carboxymethylcellulose plasticized in hydrocarbon gel(Plastibase; Contract Pharmaceuticlas, 
Canada) was used as a carrier of rhEGF.  
 
2.3.2- Surgical procedures 
A total of 84 soft tissue wounds were experimentally created in 14 animals(n=6/animal; 
Supplement Table.1) by adapting a previously reported defect model of the masticatory mucosa 
of the palate(Thoma et al.,2012,2016; Ayvazyan et al.,2011)(Fig.1a,b). 
10mm–diameter cylindrical wounds were obtained by harvesting oral soft tissue using a biopsy 
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ridges, leaving the periosteum and part of the submucosa exposed.  In order to standardize 
surgical procedures, individual stents with six 10mm-diamter circular openings served as a 
guide to symmetrically allocate three equidistant wounds(4mm) to each hemi-palate(Fig.1a). 
 
2.3.3- Treatment of oral mucosa defects 
At day1-post-surgery, the following treatment modalities were randomly applied to the dogs   
following an incomplete block design, where animals were considered as experimental units 
and defects(six per dog) as subunits(Supplement Table.1):  
-Spontaneous healing: No ointment administered(negative control group; SH; N=3 dogs, n=18 
defects). 
-Topical application of vehicle(control group control group; V; N=2 dogs, n=12 defects). 
-Topical application of rhEGF: three concentrations were tested(1µg/g(EGF1), 10µg/g(EGF10), 
50µg/g(EGF50); N=3 dogs, n=18 defects for each concentration)  
In order to facilitate topical interventions, additional individual stents were prepared with 
moulding sheets(Durasoft, Germany) deprived from any medicinal properties(Fig.1c). For each 
defect, 240 mm3 of the ointment was transferred to the stent, which was then applied on the 
upper jaw. After 10 minutes, the stent was removed, and the ointment was wiped off from the 
palatal mucosa. 
 
Administration was repeated twice per day with a 9h-interval(9am, 6pm) in each dog by 
laboratory workers blinded to the treatment agents from day 1 post-surgery until animals were 
euthanized. In the group SH, the same procedure was performed while no ointment was applied 
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2.3.4- Follow-up 
Before surgery, immediately after surgery and at post-surgery day(PSD) 4, 8, 12, and 16, 
impressions and clinical photographs were taken. Polyether impressions(Impregum F, 
Germany) of the upper jaws were taken using prefabricated individualized trays(Schmitt et 
al.,2016). 
Standardized clinical photographs were taken at an angle of 90◦ to the upper jaw and a distance 
of 80cm using identical resolution, exposure and enlargement(Rennert et al.,2009)  
 
2.3.5- Biopsies and histological processing 
At PSD8 and 16, animals were sacrificed by an intravenous injection of potassium chloride (Jeil, 
Korea) under general anaesthesia. Full thickness mucosa was gently separated from the palatal 
bone using a periosteal elevator and tissue specimens were separated.  Each biopsy was fixed in 
10% neutral-buffered formalin solution and embedded in paraffin. The tissue blocks were 
sectioned in a frontal plane at the most central aspect of the wounds and 5µm-thickness serial 
slices were cut using a microtome. Three consecutive slides from the center of the wounds were 
selected and prepared for staining(Ayvazyan et al.,2011). The slides were scanned on a high 
throughput Panoramic Scan(3DHistech, Hungary) and each section image was visualized using 
Case viewer(3DHistech, Hungary). 
 
2.4- Analyses 
2.4.1- Clinical photograph analysis 
Photographical recordings of the wounds(before and immediately after surgery, PSD4, 8, 12 and 
16) were imported into a software program(ImageJ, NIH, USA) to calculate the surface area 
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2.4.2- Three-dimensional analysis of the wounds 
For volumetric evaluation of tissue repair, impressions obtained before surgery, directly after 
surgery, and at PSD4, 8, 12, and 16 were poured out(Dentona, Germany). Retrieved casts were 
optically scanned using an industrial scanner(ATOS II SO4, Germany) and a software(ATOS, 
Germany) that allowed superimposing the three-dimensional data of the virtual dental 
models(Schmitt et al.,2016)(Fig.1f).  
 
Regions of interest(ROIV) were individually set by precisely selecting the wound margins in 
each defect from dental models obtained at the different intervals form baseline surgery for 
comparative measurements. The variations of tissue volume(Integrated distances in mm3, 
Schmitt et al.,2016) was thereafter calculated.  
 
2.4.3- Histological analyses  
Following staining with H&E and Masson’s Trichrome, wound remodelling, inflammation and 
angiogenesis were histologically assessed by quantitative image analysis of the following 
parameters(Fig.1g): 
-New Epithelium and Wound Gap: The length of the epithelium covering the wound’s 
connective tissue(New epithelium; µm) and the length of line segment between defect’s 
margins (Wound gap; µm)were calculated(Lemo et al.,2010). 
-Granulation Tissue and Collagen Areas: A rectangular region of interest(ROI1) 
encompassing the central superficial area of the wound was defined to semi-automatically 
quantify granulation tissue and collagen formation using a digital image software 
program(Photoshop, Adobe, USA). Masson’ trichrome stained sections, magnified at 30x, 
were used to easily distinguish the histological structures through their typical colours 
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image, the epithelium and the fibrin clot were manually selected and excluded. The 
remaining pixels in the ROI1 indicating the area of the granulation tissue, were measured 
and expressed as a percentage of the total pixels of the ROI1. In order to quantify the 
collagen of the granulation tissue area, collagen pixel red green blue (RGB) values were 
recorded at 5 randomly selected points to obtain an average pixel RGB value representative 
of the collagen content. This RGB value was set as a threshold to select all the blue pixels 
per image using the Select > Color Range function with a “fuzziness” value of 70(Grasman et 
al.,2015).  The thresholded pixels were expressed as a percentage of the granulation tissue 
area.  
-Inflammatory cells, Fibroblasts and Vessels: A 100-point grid region of interest(ROI2) 
was overlaid on images of the central superficial area in H&E stained slides magnified at 
200x(Image J). Points were counted coinciding with the following components: 
inflammatory cells, fibroblasts and blood vessels. 
 
2.4.4- Immunohistochemical analysis  
In order to detect the proliferative pattern of oral keratinocytes in the epithelial compartment, 
antibody against rabbit anti Ki-67(ab15580, Abcam, USA) was used for heat-induced antigen 
retrieval with a developing at 4◦C overnight with secondary antibody kits and DAB as the 
chromogen according to the respective protocol. The negative control was achieved staining the 
slide without treatment of the primary antibody to evaluate false positive staining.  
The number of positive keratinocytes was calculated using a region of interest(ROI3)(Safferling 
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2.4.5. Statistical analysis 
Mean and standard deviation values of clinical and histomorphometrical parameters were 
calculated for each experimental group. Kruskal-Wallis test with Dunnett’s test for post-hoc 
analysis were used to quantify differences between groups with p≤0.05 considered as 
significant. Sample size calculation was based on intra-individual evaluation of wound closure 
with a difference of 60%, SD 2-8%(Ayvazyan et al.,2011), a significance level of 5% and 80% 
power, leading to a total animal number of at least 10. 
 
3- RESULTS 
3.1- Clinical wound area  
Photographic recordings at PSD4, 8, 12 and 16 demonstrated a constant decrease of the wound 
areas over time in all groups(Fig.2a,b). From PSD8 to PSD16, group EGF1 displayed the smallest 
mean wound area, while the largest was observed in group EGF50. 
At PSD4, mean wound areas were 70.51±4.43mm2, 60.37±8.1mm2, 62.51±3.36mm2, 
61.88±8.25mm2 and 65.31±11.91mm2 in groups SH, V, EGF1, EGF10 and EGF50 respectively.  
At PSD8, the mean values of the defect areas were 52.01±13.16mm2, 34.64±5.54mm2, 
29.89±14.93mm2, 31.71±9.38mm2 and 58.73±25.51mm2 in SH, V, EGF1, EGF10 and EGF50 
groups respectively. 
At PSD12, the groups SH, V, EGF1, EGF10 and EGF50 exhibited mean values of respectively 
25.58±10.34mm2, 22.01±13.9mm2, 4.83±1.99mm2, 15.83±10.84mm2, 51.15±31.49mm2. 
At PSD16, the mean areas were 13.19±2.73mm2, 17.56±12.89mm2, 1.76±2.19mm2, 
7.04±5.08mm2, 29.53±19.96mm2 in SH, V, EGF1, EGF10 and EGF50 corresponding respectively 
to a closure of 83.2%, 77.6%, 97.8%, 91% and 62.4% of the initial wound area. 
Differences between groups reached statistical significance at PSD8 for V, EGF1 and EGF10 
when compared to SH and EGF50(p<0.05). At PSD12 and PSD16, statistical difference was 














This article is protected by copyright. All rights reserved. 
3.2- Volumetric assessment of wound repair 
The results of the volumetric measurements, summarized in Table 1 and illustrated in Fig.3, 
demonstrated that a similar tissue volume was harvested from the palatal mucosa in all groups 
at baseline(i0-i1)(p>0.05). At PSD4(i1-i2), tissue formation was observed in all defects with a 
mean volume of 98.09±23.51mm3, 119.63±28.3mm3, 135.84±mm3, 126.26±mm3 and 
103.89±mm3 in respectively SH, V, EGF1, EGF10 and EGF50 groups.  At PSD8(i1-i3), however, a 
decrease of tissue volume was found in all groups but EGF10. The mean volumes at day 8 were 
76.02±20.45mm3, 94.49±19.33mm3, 116.38±26.76mm3, 133.12±23.79mm3, 81.78±34.59mm3 in 
respectively SH, V, EGF1, EGF10 and EGF50 groups. Subsequently, the highest tissue volumes 
were found at PSD12(i1-i4) in group EGF10(143.8±19.4mm3), and at PSD16(i1-i5) in group 
EGF1(136.6±23.12mm3), closely followed by EGF10(136.28±37.18mm3). For both time points, 
the lowest was displayed by EGF50 group(74.74±51.23mm3 at PSD12, 71.71±12.24mm3 at 
PSD16). Statistical significance was observed at PSD8(i1-i3) between EGF10 and all 
groups(p<0.05) except EGF1; and at PSD12(i1-i4) and PSD16(i1-i5) for EGF50 as compared to 
EGF1 and EGF10(p<0.05).  
 
 3.3- Histological analysis of healing kinetic 
EPITHELIUM LAYER 
DAY 8 POST-SURGERY: Compared with SH, V and EGF50 where sparse and bare epithelial 
layers were formed at the wound site, epithelial cells showed a clear tendency to migrate 
from the edges of normal mucosa toward the centre of the wounds in groups EGF1 and 
EGF10(Supplement Fig. 1). As illustrated in Fig.2c, the histomorphometrical measurements 
showed that the wound gap was the smallest in groups EGF1 and EGF10. Mean values were 
6.37±1.38mm, 4.75±0.76mm, 4.22±1.57mm, 4.67±1.35mm and 6.9±0.81mm in respectively 
groups SH, V, EGF1, EFG10 and EGF50. In addition, EGF1 displayed the longest mean length 
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3.85±1.25mm, 5.53±1.3mm, 4.82±0.19mm and 3.1±1.31mm in respectively SH, V, EGF1, 
EFG10 and EGF50. Statistical difference was observed for the mean wound gap in V, EGF1 
and EGF10, in comparison with EGF50 (p<0.05). Similarly, the difference between 
epithelium length in EGF1 and EGF10 compared to the other groups was 
significant(p<0.05).  
DAY 16 POST-SURGERY: Wounds were observed to reach full closure by reepithelialization 
in the majority of the samples in EGF1 and EGF10(5/6 and 10/12 respectively) while the 
epithelium was still not completely formed at the centre of the wounds in SH, V and 
EGF50(Fig.4a). This was verified by the wound gap measurement in groups EGF1 and 
EGF10 showing the fastest decrease upon PSD16(6.5 and 5.3 folds respectively). The mean 
values of new epithelium length were 7.21±1.63mm, 7.14±1.43mm, 12.94±1.44mm, 
11.48±2.49mm and 6.58±2.39mm in SH, V, EGF1, EGF10 and EGF50 respectively.  For both 
histomorphometrical parameters, EGF1 and EGF10 displayed significant differences when 
compared to group SH and EGF50(p<0.05). 
 
SUB-EPITHELIAL LAYER: 
DAY 8 POST-SURGERY: In all groups, the subepithelial region showed fibroblasts migrating 
from the wound bed and granulation initiating, as the defect site was replaced with 
regenerating tissue. In the magnified images of the middle region, connective tissue 
appeared heavily infiltrated with inflammatory cells between which small vessels could be 
detected with a sporadic distribution of few fibroblasts(Fig.4a,Supplement Fig.2). The 
histomorphometrical analysis showed no differences of vessels proportion between 
groups. By contrast, EGF10 group harboured the smallest inflammatory infiltrate among all 
groups(38.9±11%) as well as the highest proportion of fibroblasts(22.9±13%, 
p<0.05)(Fig.4b). The amount of collagen and granulation tissue was the highest in the 
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respectively)(Fig.5). The differences between EGF10 and the other groups for the 
proportions of collagen, granulation tissue and inflammation reached statistical 
significance(p<0.05). 
DAY 16 POST-SURGERY: Examining the central subepithelial region of wounds belonging to 
EGF1 and EGF10, collagen fibres appeared thicker with a corrugated structure, whereas 
highly disordered in SH, V and EGF50, as evidenced with the H&E staining(Fig.4a). The 
histomorphometry showed a significantly higher deposition of collagen, faster regression of 
granulation tissue and lower proportion of inflammatory infiltrate in EGF1 and EGF10 in 
comparison with SH, V, and EGF50(p<0.05)(Fig.4b and Fig.5).  The collagen area amounted 
33±8.8%, 37.2±3.1%, 57.7±5.4%, 57.5±15.2% and 44.4±15.9% in respectively SH, V, EGF1, 
EGF10 and EGF50. The area of granulation tissue represented 45.5±10%, 45.2±4.2%, 
21.3±5.2%, 24.9±14.5% and 27.9±11.5% in respectively SH, V, EGF1, EGF10 and EGF50. 
The inflammatory infiltrate proportion reached 70.6±11.8%, 42±25.4%, 26.5±23.7%, 
13.6±14.6% and 47±31.2% in respectively SH, V, EGF1, EGF10 and EGF50.  In addition, 
fibroblasts and vessels proportions remained the highest in EGF10 group with statistical 
difference as compared to the other groups(p<0.05). 
 
3.4- Keratinocytes proliferative activity 
As shown in Fig.6.a, few positive nuclei along the basal cell layer could be observed in the edges 
of the wounds from SH, V or EGF50 at PSD8 and PSD16. However, a clear increased expression 
of Ki67 within basal and immediate supra-basal cells was seen from PSD8 to PSD16 in EGF1 and 
EGF10.  This was confirmed by the histomorphometrical analysis demonstrating a significantly 
higher keratinocytes proliferation in these groups at PSD16(p<0.05). The immunoreactivity for 
Ki67 was 399.2±165.1cells/field, 579.4±180.9cells/field, 921.9±202.3cells/field, 
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4- DISCUSSION 
There have been through and accelerated efforts to improve oral wound healing. These 
endeavours have been motivated by the need for a hastened soft tissue healing following 
periodontal and peri-implant surgery. Although the oral mucosa is endowed with the capacity to 
repair itself, closure is anticipated to be significantly delayed when surgical wounds are readily 
exposed to oral bacteria and left to heal by secondary intention. Because complications of open 
wounds may hamper the treatment outcomes, it is believed that surgical wounds healing by 
secondary intention require local care(Greenstein et al.,2008). This study provides a hitherto 
novel approach for boosting the innate healing potential by which rhEGF is engaged in a 
productive repair of oral mucosa wounds. 
 
The hypothesis of the present study encompasses not only the study of the rhEGF 
biological potential, but also the screening of the clinically relevant doses. A total of fourteen 
dogs was employed to discriminate the dose-dependent effect of rhEGF on oral wound repair. 
Considering the paucity of the data for the oral mucosa(Kim et al.,2017), three concentrations 
were selected in accordance with the literature addressing the treatment of skin wounds in 
humans(Brown et al.,1989; Wang et al.,2002; Fernández‐Montequín et al.,2009; Martí-Carvajal 
et al.,2010) or animals(Hong et al.,2006; Gainza et al.,2015) with rhEGF. Then, rhEGF 
incorporated in an ointment vehicle was tested in a discriminating pre-clinical model. The 
experimental standardized wound size, fixed wounding protocol, and the use of canine palatal 
mucosa as a wounding substrate allowed to overcome some of the challenges associated with in 
vivo wound healing studies, that is, the lack of apposite murine wound healing model for oral 
soft tissues. The morphological features of oral epithelium and molecular patterns in connective 
tissue of the healing oral palate from dog are the most similar to humans as compared to other 
species including rodents and pigs(Sa et al.,2016;2017). Here, the harvested tissues with a mean 
thickness varying between 1.32mm and 1.49mm, resulted in defects that included epithelium, 
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wounding, time points at which the healing masticatory mucosa exhibited typical signs of 
erythema/oedema or wound closure respectively(Häkkinen et al.,2012). Given the excisional 
nature of the wounds, healing requires the closure of the wound site by formation of new 
connective tissue and coverage by epithelium, events that might be impaired by direct insults 
from the oral commensal flora(Nooh et al.,2003). Growth factors, such as EGF, are poised to 
improve wound repair in the present setting of acute excisional injuries(Davidson et al.,1993). 
 
Consistent with this assumption was the healing in wounds topically treated with rhEGF 
1µg/g and 10µg/g, that is characteristic of a regenerative response including efficient resolution of inflammation, promotion of an extra-cellular matrix(ECM)– rich granulation tissue, and a 
superior rate of re-epithelialization(Gurtner et al.,2008). A prime example is the rapid closure of 
the excisions receiving topical preparations in EGF1 and EGF10 as evidenced clinically(gross 
wound area) and confirmed histologically(wound gap), and may be attributable to a plethora of 
biochemical events downstream of the binding of EGF to its transmembranic 
receptors(Nickoloff el al.,1988; McCawley et al.,1998; Hashimoto et al.,2000; D’Alessio et 
al.,2008). In the same vein, the analysis of the proliferative activity as reflected by Ki-67, a 
protein produced in mitosis G1 and S phases, was found to be superior in sites receiving 1µg/g 
and 10µg/g of rhEGF as compared to EGF50 and controls at PSD8 and PSD16. In contrast with 
the impaired wound closure observed in EGF50, the overall quicker reconstruction of the 
epithelium in EGF1 and EGF10 confirms previous reports using settings of skin wounds in 
pigs(Hong et al.,2006) or humans(Yang et al.,2016). 
 
Once the epithelial barrier has been re-established, remodelling of the granulation tissue 
concomitant with the deposition of cross-linked collagen fibres are key events in the course of 
oral mucosa healing(Weinreb et al.,2015). Comparably to previous studies, the significant 
production of hypercellular granulation tissue(Kondo et al.,2012) at 8 days as well as the 
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herein the faster healing in rhEGF-treated sites, particularly with the 1µg/g and 10µg/g regimen 
at the opposite of the 50µg/g concentration. Through the activation of mitogen-activated 
protein kinase-dependent pathways(Smith et al.,2009), not only EGF stimulates gingival 
fibroblasts to remove fibrin clot (Chiquet et al.,2015), but also activates matrix metalloproteins, 
major ECM-proteolytic enzymes involved in the healing of human acute gingival wounds (Smith 
et al.,2009). Surprisingly, while fibroblasts are poised to reduce in number during ECM 
remodelling, these cells were more numerous at PSD16 in sites treated with the concentrations 
1µg/g and 10µg/g, seemingly due to the EGF proliferative effect on these cells as previously 
reported(Irwin et al.,1994). Altogether, these histological events were translated clinically by 
the highest volumes of regenerated tissues within wounds receiving 1µg/g and 10µg/g up to 
PSD16, despite the volume diminution ascribed to the swelling subside as observed for the 
other groups.   
 
The rapid onset and regression of the inflammatory response has a crucial role in 
coordinating the process of wound healing(Gurtner et al.,2008). Less inflammatory cells were 
histologically evidenced in EFG1 and EGF10 at the opposite of SH and EGF50 where persistent 
inflammatory response up to PSD16 was found. The finding that exogenous EGF attenuates 
inflammation is in line with an existing evidence accumulated from preclinical(Heck et al.,1992; 
Kim et al.,2010) and clinical trials(Shin et al.,2015), and may be linked to a substantial decrease 
of histamine release by monocytes(Babül et al.,2004). Inflammatory cells secrete essential 
cytokine and growth factors necessary for angiogenesis and stromal cell migration(Eming et 
al.,2007). With regard to a recent report demonstrating a substantial increase in vascular 
endothelial growth factor (VEGF) synthesis by human gingival fibroblasts exposed to EGF in 
vitro(Pansani et al.,2017), the elevated neovascularization EFG1 and EGF10 is not a surprising 
finding and strongly suggests the ability of rhEGF to promote oral mucosa wound healing by 
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However, an unexpected outcome was the failure of wounds in EGF50 to reepithelialise, 
which combined with their persistent inflammatory response suggests the development of 
chronic lesions(Koivisto et al.,2012). Soft tissue swelling and excessive inflammatory response 
were reported in wounds treated with highly-dosed regimen of growth factors(Zara et al.,2011). 
In animal settings of skin wounds, topical treatment with 10µg/ml EGF delayed the closure of 
acute lesions(Breuing et al.,1997) while less proliferative activity of keratinocytes was depicted 
for doses of rhEGF superior to 10µg/g(Hong et al.,2006).  It is believed that a downregulation of 
epidermal growth factor receptors occurs when cells are maximally stimulated with exogenous 
EGF, ultimately leading to the deceleration of the wound healing process(Mathers et al.,1989). 
The decrease of lipocortin activity resulting in prostaglandin upregulation and inflammation 
exacerbation was also reported to explain the detrimental effect of EGF’s high dosages(Tripathi 
et al.,1990). The caveat is that dose-associated events might also include neoplastic 
transformation(Zeng et al.,2014), the short duration of this study, however, limits any 
conclusion on the effects of high doses of rhEGF as well as the maturation of healing tissue for a 
longer span of time. 
 
5- CONCLUSION 
Within the limitations of the present study, the observations herein demonstrate the efficacy of 
topically administrated human recombinant EGF in promoting early healing of open soft tissue 
wound in dogs. The results suggest that concentrations of 1 and 10ug/g in ointment accelerates 
wounds closure due to the increase of keratinocytes proliferative activity in the epithelial layer; 
and fastens neovascularization and inflammation regression in the subepithelial compartment. 
In contrast, a persistent inflammatory response and a delay of the wound closure were 
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TABLES 
 
Table 1: Showing the outcomes of the volumetric analyses for the control (negative control; SH, vehicle; V) and the test groups (EGF1, EGF10 and EGF50). 
Mean, median and standard deviation (SD) is given for each parameter. 
a: significant difference with SH, V and EGF50 groups (p<0.05). 
b: significant difference with EGF50 (p<0.05). 
c: significant difference with SH (p<0.01). 
d: significant difference with EGF50 (p<0.001). 
Outcomes of volume measurements (integrated distances, mm3) comparing the situation before surgery (i0), 4 days after 
surgery (i2), 8 days after surgery (i3), 12 days after surgery (i4) and 16 days after the surgery (i5) with the situation directly 
after surgery (i1) 
i0-i1 i1-i2 i1-i3 i1-i4 i1-i5 
Mean Median SD Mean Median SD Mean Median SD Mean Median SD Mean Median SD 
SH -151.3 -140.93 47.58 98.09 90.9 23.51 76.02 65.65 20.45 87.39 66.87 42.8 85.23 68.3 38.97 
V -157.32 -160.22 45.78 119.63 125.8 28.3 94.49 91.39 19.33 89.82 90.84 14.47 77.73 102.27 12.24 
EGF1 -163.25 -164.84 34.17 135.84 140.09 41.08 116.38 123.49 26.76 124.32 b 124.8  30.84 136.6b 129.03 23.12 
EGF10 -147.2 -152.2 38.79 126.26 130.2 57.9 133.12 a 130.62  23.79 143.8 c, d 137.6  19.4 136.28 b 131.4  37.18 
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FIGURE LEGENDS 
Figure 1: a-d: Surgical procedure, rhEGF administration and follow-up. Using a prefabricated 
stent (a), punch biopsies were harvested creating 6 defects on the hard palate mucosa of each 
dog (b). An equivalent volume (≈240 mm3) of ointment (vehicle, 1, 10 and 50µg/g) was 
transferred to the stent using a spatula on the location of each defects. The stent was then 
applied on the upper jaw and an intimate contact of both jaws was maintained to immobilize the 
stents for 10 minutes. In the Spontaneous Healing group, the same procedure was performed 
while no ointment was applied on the stent (c). Healing was monitored using clinical 
photographs and impressions (d) (Bar=5mm). 
 e-g: Clinical, three-dimensional and histological analyses. On photographical recordings of the 
wounds before, immediately after surgery, 4, 8, 12 and 16 days following surgery, the wound 
area (mm2) was calculated as the surface area covered by unkeratinized tissue (dashed area) 
(a). Tissue volume variations were evaluated in regions of interest (ROIV) on superimposed 
scans of digitized casts at the different time-points (Blue: immediately after surgery, Grey: at 
post-surgery day-4) (b). Histological analysis was performed using ROI1 positioned at the centre 
of the biopsy along its surface, a rectangular-shaped ROI2 (8mm/1.5mm) and ROI3 
encompassing the epithelium layer (12mm length segment divided in five equivalent fields of 
x200 magnification).  
 
 
Figure 2: a-  Representative clinical photographs of wounds healing following surgery, at post-
surgery days 4, 8, 12 and 16.   b- Remaining wound area from surgery to post-surgery day 16. c- 
Histological evaluation of epithelium length (left) and wound gap (right).   
 
(      : Spontaneous healing (SH);        : Vehicle (V);        : EGF1;        : EFG10;         : EGF50 ;  
a: significant difference with V, EGF1 and EGF10 (p<0.05); 
b: significant difference with V, EGF1 and EGF10(p<0.01);  
c: significant difference with SH, V, EGF1 and EGF10 (p<0.01);  
d: significant difference with SH, V, EGF1 and EGF10 (p<0.05); †, ‡: significant difference with V, EGF1 and  (p<0.05);  
Significance level set at *: p<0.05, ***: p<0.01,****: p<0.001; 
Bar=5mm) 
 
Figure 3: Soft tissue volume alterations in defects receiving vehicle (V), 1µg/g (EGF1), 10µg/g 
(EGF10) and 50µg/g (EGF50) of rhEGF or spontaneously healing (SH) between immediate post-
surgery and day 16. Occlusal view of the regions of interest (top row) and their transversal 
sections (lower row) are illustrated. The thickness differences in the soft tissues (mm) are displayed on the coloured scale at the bottom of the figure. Blue areas represent a decrease in 
thickness, green areas a comparable thickness and yellow and red areas an increase in 
thickness. (Dashed line: reference for transversal section of the region of interest; Black 
bar=2.5mm) 
 
Figure 4: a- Representative H&E staining of the palatal mucosa unwounded or 8 and 16 days 
following surgery, illustrating the healing process at the centre of the defects (see Supplement 
Fig. 2). Boxed areas are high magnifications (x400) shown for unwounded (on the right) and 
wounded tissues at days 8 and 16 (below). Asterix indicates vessel-like structures, dotted lines 
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quantification of the proportion of fibroblasts, vessels and inflammatory cells-like structures in 
the central superficial area of the wounds 8 and 16 days following surgery (region of interest 
ROI1) (Black bar= 100µm; yellow bar= 20µm).  
(SH: spontaneous healing; V: vehicle) 
a: significant difference with SH, V, EGF1 and EGF50 (p<0.05); 
b: significant difference with SH, V, EGF1 and EGF50 (p<0.01); 
c: significant difference with SH, V and EGF50 (p<0.05); 
d: significant difference with SH, V and EGF1 (p<0.05) 
*: significant difference between day 8 and day 16 (p<0.05);  
**: significant difference between day 8 and day 16 (p<0.01). 
 
Figure 5: Graphical representations of granulation tissue and collagen proportions at post-
surgery days 8 and 16 in wounds healing spontaneously (SH) or receiving vehicle (V), 1µg/g 
(EGF1), 10µg/g (EGF10) and 50µg/g (EGF50) of rhEGF ointments.  
(a: significant difference with SH, V, EGF1 and EGF50 (p<0.05); 
b: significant difference with SH, V and EGF50 (p<0.05); 
*: significant difference between day 8 and day 16 (p<0.05);  
**: significant difference between day 8 and day 16 (p<0.01). 
 
Figure 6: a- Immunohistochemical staining of normal (top row) and healing palatal mucosa 
(spontaneously healing, NC; vehicle, V; rhEGF 1µg/g, rhEGF 10µg/g and rhEGF 50µg/g groups) 
with antibody against Ki67. Figures illustrates proliferative activity of basal keratinocytes at the 
epithelium of wound edges (Bar=50µm). b- Graphical representation of Ki67 positive cell 
number per field. Dashed red line indicates the mean number of Ki67 positive cells per filed in 
the epithelium of unwounded mucosa. 
 
Supplement Figure 1:  Wound closure and reepithelialization at post-surgery day 8 illustrated by Masson’s trichrome staining of oral mucosa wounds from spontaneously healing (NC,a), 
vehicle (V, b), EGF1 (c), EGF10(d) and EGF50 (e). Dashed line represents epithelium length, 
black arrow indicates non-wounded tissue margin, white arrow shows the extremity of wound 
epithelium and ulcer margin. (Bar= 500 µm). 
 
Supplement Figure 2:  Representative H&E staining of oral mucosa sections at 8 days (A)and 16 
days (B) following surgery. Clinical wound repair is represented, and histological healing 
process is shown at the left (a, d, g, j, m), centre (b, e, h, k, n) and right of the wounds. White 
dashed lines on histological sections indicate the boundaries between the wound and the 
surrounding normal tissue. Magnified view (x100, p-t) of the regions in black pane are 
presented on the left column of A and B. Asterix indicates vessel-like structures, black dotted 
lines represent boundaries between fibrin clot and granulation tissue (Black bar= 100 µm, 
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